More than 600,000 bottles of the blood pressure medication ramipril have been recalled across the United States due to concerns over potential contamination.
The FDA issued the recall after discovering that the drug contained ingredients from an uninspected and unapproved manufacturing facility in India.
What is Ramipril?
Ramipril is a widely prescribed medication, used by more than 2.4 million Americans annually, to manage high blood pressure by relaxing blood vessels. While no adverse events have been reported so far, the FDA cautions that the capsules could pose a contamination risk, though the overall threat to public health is considered low.
Details of the Recall
The recall involves bottles of ramipril produced by Lupin Pharmaceuticals, an Indian company. The affected capsules are available in three strengths:
- 2.5 mg
- 5 mg
- 10 mg
The bottles contain 90, 100, or 500 capsules and have expiration dates extending to July 2026. Initially, the recall targeted the 5mg and 10mg strengths, but on November 19, the 2.5mg dose was added.
FDA Findings
The FDA revealed that the active pharmaceutical ingredient (API) in the capsules was sourced from a manufacturer in Goa, India, which had not undergone proper inspection or approval. This triggered a Class II recall, which indicates a low probability of severe injury or death but acknowledges the potential for adverse effects.
What Should Consumers Do?
CONTINUE READING NEXT PAGE
Advertisement:
Once You Learn This, You Will Never Throw Avocado Pit Away
Discover the Joy of Homemade Apple and Carrot Juice
Discover the natural marvel that turmeric may do for your oral health and how it might change your life.
Pineapple Cheesecake
One of the hidden secrets you must try: Salt along with bay leaves
NO-BAKE COCONUT CREAM PIE
Title: Young Girl Thought She Found a Lizard in the Woods When a Vet Saw Her and Shouted, « Step Away! »
Rotel Cream Cheese Sausage Balls – Don’t LOSE this Recipe
Why do Japanese people sit facing forward in the toilet?
